Acta Med. 2014, 57: 30-33
https://doi.org/10.14712/18059694.2014.6
DENOSUMAB ASSOCIATED WITH BONE DENSITY INCREASE AND CLINICAL IMPROVEMENT IN A LONG-TERM HEMODIALYSIS PATIENT. CASE REPORT AND REVIEW OF THE LITERATURE
Crossref Cited-by Linking
- Thongprayoon Charat, Acharya Prakrati, Aeddula Narothama Reddy, Torres-Ortiz Aldo, Bathini Tarun, Sharma Konika, Ungprasert Patompong, Watthanasuntorn Kanramon, Suarez Maria Lourdes Gonzalez, Salim Sohail Abdul, Kaewput Wisit, Chenbhanich Jirat, Mao Michael A., Cheungpasitporn Wisit: Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis. Arch Osteoporos 2019, 14. <https://doi.org/10.1007/s11657-019-0587-0>
- Thongprayoon C., Acharya P., Acharya C., Chenbhanich J., Bathini T., Boonpheng B., Sharma K., Wijarnpreecha K., Ungprasert P., Gonzalez Suarez M.L., Cheungpasitporn W.: Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies. Osteoporos Int 2018, 29, 1737. <https://doi.org/10.1007/s00198-018-4533-6>
- Fülöp Tibor, Koch Christian A., Farah Musa Abdeen R., Clark Christopher M., Gharaibeh Kamel A., Lengvársky Zsolt, Hamrahian Mehrdad, Pitman Karen T., Dixit Mehul P.: Targeted surgical parathyroidectomy in end‐stage renal disease patients and long‐term metabolic control: A single‐center experience in the current era. Hemodialysis International 2018, 22, 394. <https://doi.org/10.1111/hdi.12639>
- Festuccia Francescaromana, Jafari Maryam Tayefeh, Moioli Alessandra, Fofi Claudia, Barberi Simona, Amendola Stefano, Sciacchitano Salvatore, Punzo Giorgio, Menè Paolo: Safety and efficacy of denosumab in osteoporotic hemodialysed patients. J Nephrol 2017, 30, 271. <https://doi.org/10.1007/s40620-016-0334-1>
- Afshan Sabahat, Farah Musa Abdeen R., Echols Vonda, Lerant Anna A., Fülöp Tibor: Persisting Hypocalcemia After Surgical Parathyroidectomy: The Differential Effectiveness of Calcium Citrate Versus Calcium Carbonate With Acid Suppression. The American Journal of the Medical Sciences 2017, 353, 82. <https://doi.org/10.1016/j.amjms.2016.04.007>
- Takami Hiroya, Washio Kazunori, Gotoh Hiromichi: Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study. International Journal of Nephrology 2017, 2017, 1. <https://doi.org/10.1155/2017/6218129>
- Sklyanik Igor A., Egorova Daria N., Dzeranova Larisa K., Pigarova Ekaterina A.: Correction of mineral and bone disorders in a patient with long-standing diabetes mellitus type 1 on hemodialysis therapy. Obes. metabol. 2016, 13, 48. <https://doi.org/10.14341/omet2016248-55>
- Wada Yukihiro, Iyoda Masayuki, Iseri Ken, Arai-Nunota Noriko, Saito Tomohiro, Hamada Toma, Tachibana Shohei, Ikeda Misa, Shibata Takanori: Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism. Tohoku J. Exp. Med. 2016, 238, 205. <https://doi.org/10.1620/tjem.238.205>
- Denosumab/methylprednisolone. Reactions Weekly 2015, 1570, 71. <https://doi.org/10.1007/s40278-015-5643-y>
- Makras Polyzois, Delaroudis Sideris, Anastasilakis Athanasios D.: Novel therapies for osteoporosis. Metabolism 2015, 64, 1199. <https://doi.org/10.1016/j.metabol.2015.07.011>